查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538256

诊断放射性同位素市场报告：2030 年趋势、预测与竞争分析

Diagnostic Radioisotope Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

诊断放射性同位素的趋势和预测

到 2030 年，全球诊断放射性同位素市场预计将达到 64 亿美元，2024 年至 2030 年复合年增长率为 6.7%。该市场的主要驱动因素是对疾病早期和准确诊断的需求不断增长、诊断成像方式的不断进步以及对α放射性同位素的需求不断增长。全球诊断放射性同位素市场的未来前景广阔，为医院、专科诊所、诊断中心以及学术和研究机构市场提供了机会。

诊断放射性同位素：按细分市场

该研究包括以放射性同位素、成像方式、应用、最终用途和地区对全球诊断放射性同位素的预测。

诊断放射性同位素市场洞察

Lucintel 预测，99mTechnetium预计在预测期内达到最高成长。

在这个市场中，专科诊所预计在预测期内将出现最高成长。

在预测期内，北美仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球诊断放射性同位素市场预计将达到 64 亿美元。

Q2.市场成长预测是多少：

A2. 2024 年至 2030 年，全球诊断放射性同位素市场预计将以 6.7% 的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是对疾病早期和准确诊断的需求不断增长、诊断成像方式的不断进步以及对α放射性同位素的需求不断增长。

Q4.市场的主要细分市场是：

A4. 诊断放射性同位素市场的未来对于医院、专科诊所、诊断中心以及学术和研究机构市场来说是充满希望的。

Q5.市场的主要企业是：

A5. 主要诊断放射性同位素公司如下：

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测Technetium 99m 将在预测期内达到最高成长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 预计北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球诊断放射性同位素市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球诊断放射性同位素市场趋势（2018-2023）与预测（2024-2030）
  • 按放射性同位素分類的全球诊断放射性同位素市场
    • Technetium99m
    • 铊201
    • 镓67
    • 碘123
    • FDG
    • 铷82
    • 其他的
  • 按成像方式分類的全球诊断放射性同位素市场
    • SPECT
    • PET
    • β放射体
  • 全球诊断放射性同位素市场（按应用）
    • 诊断
    • 治疗
  • 按最终用途分類的全球诊断放射性同位素市场
    • 医院
    • 专科诊所
    • 诊断中心
    • 学术/研究机构
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球诊断放射性同位素市场（按地区）
  • 北美诊断放射性同位素市场
  • 欧洲诊断放射性同位素市场
  • 亚太地区诊断放射性同位素市场
  • 其他地区诊断放射性同位素市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球诊断放射性同位素市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球诊断放射性同位素市场的能力
    • 全球诊断放射性同位素市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes
简介目录

Diagnostic Radioisotope Trends and Forecast

The future of the global diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets. The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Diagnostic Radioisotope by Segment

The study includes a forecast for the global diagnostic radioisotope by radioisotope, imaging modality, application, end use, and region.

Diagnostic Radioisotope Market by Radioisotope [Shipment Analysis by Value from 2018 to 2030]:

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others

Diagnostic Radioisotope Market by Imaging Modality [Shipment Analysis by Value from 2018 to 2030]:

  • SPECT
  • PET
  • Beta Emitters

Diagnostic Radioisotope Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic
  • Therapeutic

Diagnostic Radioisotope Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

Diagnostic Radioisotope Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Diagnostic Radioisotope Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diagnostic radioisotope companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the diagnostic radioisotope companies profiled in this report include-

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes

Diagnostic Radioisotope Market Insights

Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.

Within this market, specialty clinic is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Diagnostic Radioisotope Market

Market Size Estimates: Diagnostic radioisotope market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Diagnostic radioisotope market size by various segments, such as by radioisotope, imaging modality, application, end use, and region in terms of value ($B).

Regional Analysis: Diagnostic radioisotope market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different radioisotopes, imaging modalities, applications, end uses, and regions for the diagnostic radioisotope market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diagnostic radioisotope market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the diagnostic radioisotope market size?

Answer: The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030.

Q2. What is the growth forecast for diagnostic radioisotope market?

Answer: The global diagnostic radioisotope market is expected to grow with a CAGR of 6.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the diagnostic radioisotope market?

Answer: The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.

Q4. What are the major segments for diagnostic radioisotope market?

Answer: The future of the diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets.

Q5. Who are the key diagnostic radioisotope market companies?

Answer: Some of the key diagnostic radioisotope companies are as follows:

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips
  • Cardinal Health
  • Lantheus Holdings
  • Bayer
  • Bracco
  • Eckert & Ziegler
  • Nordion
  • NTP Radioisotopes

Q6. Which diagnostic radioisotope market segment will be the largest in future?

Answer: Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.

Q7. In diagnostic radioisotope market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the diagnostic radioisotope market by radioisotope (technetium-99m, thallium-201, gallium-67, iodine-123, FDG, rubidium-82, and others), imaging modality (SPECT, PET, and beta emitters), application (diagnostic and therapeutic), end use (hospitals, specialty clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Diagnostic Radioisotope Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Diagnostic Radioisotope Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Diagnostic Radioisotope Market by Radioisotope
    • 3.3.1: Technetium-99m
    • 3.3.2: Thallium-201
    • 3.3.3: Gallium-67
    • 3.3.4: Iodine-123
    • 3.3.5: FDG
    • 3.3.6: Rubidium-82
    • 3.3.7: Others
  • 3.4: Global Diagnostic Radioisotope Market by Imaging Modality
    • 3.4.1: SPECT
    • 3.4.2: PET
    • 3.4.3: Beta Emitters
  • 3.5: Global Diagnostic Radioisotope Market by Application
    • 3.5.1: Diagnostic
    • 3.5.2: Therapeutic
  • 3.6: Global Diagnostic Radioisotope Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Specialty Clinics
    • 3.6.3: Diagnostic Centers
    • 3.6.4: Academic & Research Institutes
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Diagnostic Radioisotope Market by Region
  • 4.2: North American Diagnostic Radioisotope Market
    • 4.2.1: North American Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.2.2: North American Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
  • 4.3: European Diagnostic Radioisotope Market
    • 4.3.1: European Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.3.2: European Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
  • 4.4: APAC Diagnostic Radioisotope Market
    • 4.4.1: APAC Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.4.2: APAC Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
  • 4.5: ROW Diagnostic Radioisotope Market
    • 4.5.1: ROW Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
    • 4.5.2: ROW Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Diagnostic Radioisotope Market by Radioisotope
    • 6.1.2: Growth Opportunities for the Global Diagnostic Radioisotope Market by Imaging Modality
    • 6.1.3: Growth Opportunities for the Global Diagnostic Radioisotope Market by Application
    • 6.1.4: Growth Opportunities for the Global Diagnostic Radioisotope Market by End Use
    • 6.1.5: Growth Opportunities for the Global Diagnostic Radioisotope Market by Region
  • 6.2: Emerging Trends in the Global Diagnostic Radioisotope Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Diagnostic Radioisotope Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Radioisotope Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Siemens Healthineers
  • 7.3: Koninklijke Philips
  • 7.4: Cardinal Health
  • 7.5: Lantheus Holdings
  • 7.6: Bayer
  • 7.7: Bracco
  • 7.8: Eckert & Ziegler
  • 7.9: Nordion
  • 7.10: NTP Radioisotopes